Pithi Chanvorachote Selected Research

Ubiquitin

11/2023	Simplified Synthesis of Renieramycin T Derivatives to Target Cancer Stem Cells via β-Catenin Proteasomal Degradation in Human Lung Cancer.
11/2020	Gigantol Targets MYC for Ubiquitin-proteasomal Degradation and Suppresses Lung Cancer Cell Growth.
1/2020	Novel c-Myc-Targeting Compound N, N-Bis (5-Ethyl-2-Hydroxybenzyl) Methylamine for Mediated c-Myc Ubiquitin-Proteasomal Degradation in Lung Cancer Cells.
4/2017	Zinc suppresses stem cell properties of lung cancer cells through protein kinase C-mediated β-catenin degradation.
10/2009	Nitric oxide regulates lung carcinoma cell anoikis through inhibition of ubiquitin-proteasomal degradation of caveolin-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pithi Chanvorachote Research Topics

Disease

128	Lung Neoplasms (Lung Cancer) 01/2024 - 06/2006
109	Neoplasms (Cancer) 01/2024 - 06/2006
42	Neoplasm Metastasis (Metastasis) 03/2023 - 10/2009
40	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 07/2009
16	Carcinoma (Carcinomatosis) 12/2021 - 06/2006
10	B-Cell Lymphoma (Lymphoma, B Cell) 09/2023 - 05/2015
9	Necrosis 12/2023 - 10/2011
7	Leukemia 04/2020 - 02/2013
4	Melanoma (Melanoma, Malignant) 04/2022 - 10/2011
3	Myeloid Leukemia (Leukemia, Myelocytic) 03/2022 - 12/2012
2	Neuroblastoma 02/2021 - 08/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2020 - 08/2013
2	Alopecia (Baldness) 07/2019 - 08/2011
2	Wounds and Injuries (Trauma) 07/2015 - 04/2015
1	Inflammation (Inflammations) 07/2023
1	Disease Progression 01/2023
1	Carcinogenesis 01/2023
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2022

Drug/Important Bio-Agent (IBA)

41	Proteins (Proteins, Gene)FDA Link 01/2024 - 05/2010
22	Cisplatin (Platino)FDA LinkGeneric 10/2022 - 06/2006
20	IntegrinsIBA 06/2023 - 10/2014
17	Caveolin 1IBA 10/2020 - 10/2009
11	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024 - 12/2006
11	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2020 - 10/2009
10	renieramycin MIBA 10/2021 - 01/2011
8	Propidium (Propidium Iodide)IBA 12/2022 - 10/2011
8	gigantolIBA 05/2021 - 06/2014
7	AlkaloidsIBA 12/2023 - 01/2011
7	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 09/2023 - 02/2011
7	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 10/2022 - 10/2011
7	Superoxides (Superoxide)IBA 01/2019 - 07/2009
6	AntioxidantsIBA 01/2024 - 12/2006
6	Apoptosis Regulatory ProteinsIBA 01/2024 - 05/2015
6	renieramycin TIBA 12/2023 - 05/2019
6	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 09/2023 - 12/2012
6	Cadherins (E-Cadherin)IBA 01/2022 - 03/2013
6	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2019 - 01/2015
5	PhytochemicalsIBA 01/2024 - 03/2015
5	Transcription Factors (Transcription Factor)IBA 11/2023 - 04/2017
5	CateninsIBA 11/2023 - 04/2017
5	UbiquitinIBA 11/2023 - 10/2009
5	Annexin A5IBA 09/2022 - 12/2013
4	Cytotoxins (Cytolysins)IBA 07/2023 - 06/2006
4	VimentinIBA 12/2021 - 01/2014
4	hydroquinone (Esoterica)FDA Link 10/2021 - 08/2013
4	EstersIBA 10/2021 - 11/2017
4	Hydroxyl RadicalIBA 07/2021 - 12/2010
4	Peptides (Polypeptides)IBA 01/2021 - 12/2017
4	Small Interfering RNA (siRNA)IBA 09/2019 - 01/2013
4	ZincIBA 04/2017 - 01/2014
4	Ouabain (G Strophanthin)IBA 10/2014 - 01/2013
3	Caspase 3 (Caspase-3)IBA 01/2024 - 11/2017
3	Biomarkers (Surrogate Marker)IBA 08/2023 - 07/2018
3	ResveratrolIBA 06/2023 - 09/2022
3	lusianthridinIBA 04/2023 - 01/2015
3	CurcuminIBA 09/2022 - 07/2009
3	Hormones (Hormone)IBA 12/2021 - 02/2013
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2021 - 05/2015
3	Focal Adhesion Protein-Tyrosine KinasesIBA 06/2021 - 04/2018
3	jorunnamycin AIBA 05/2021 - 01/2016
3	ElementsIBA 10/2020 - 01/2016
3	1,2,3,4-tetrahydroisoquinolineIBA 05/2019 - 01/2011
3	Thioctic Acid (Lipoic Acid)IBA 10/2017 - 12/2006
3	dendrophenolIBA 01/2016 - 01/2013
2	TubulinIBA 01/2023 - 04/2021
2	FITC-annexin A5IBA 12/2022 - 02/2020
2	Endoplasmic Reticulum Chaperone BiPIBA 10/2022 - 11/2021
2	methylamine (methylammonium)IBA 09/2022 - 01/2020
2	Oncogene Proteins (Oncogene Protein)IBA 05/2022 - 02/2020
2	Silk FDA Link 04/2022 - 04/2015
2	LigandsIBA 01/2022 - 02/2013
2	ColicinsIBA 01/2021 - 02/2020
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 01/2018
2	BromidesIBA 11/2020 - 01/2018
2	MicroRNAs (MicroRNA)IBA 07/2020 - 05/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2020 - 01/2014
2	Glutamic Acid (Glutamate)FDA Link 02/2020 - 05/2017
2	Dasatinib (BMS 354825)FDA Link 09/2019 - 01/2018
2	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 10/2018
2	phoyunnanin EIBA 11/2018 - 12/2017
2	thiazolyl blueIBA 01/2018 - 12/2013
2	cycloartobiloxanthoneIBA 01/2018 - 11/2017
2	CaspasesIBA 01/2018 - 12/2006
2	AnionsIBA 04/2017 - 08/2013
2	quinone (benzoquinone)IBA 12/2016 - 08/2013
2	4,6- dimethoxy- 9- (4- methoxybenzyl)- 8- (2- (4- methoxyphenyl)ethyl)- 9H- xanthene- 2,3,5- triolIBA 04/2015 - 01/2015
2	Cardiac GlycosidesIBA 03/2014 - 01/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 02/2013
2	artonin EIBA 08/2013 - 12/2012
1	CatalaseIBA 09/2023
1	oligochitosanIBA 07/2023
1	ChitosanIBA 07/2023
1	ThiazolesIBA 03/2023
1	Histone Deacetylase 6IBA 01/2023
1	EnzymesIBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	Bortezomib (Velcade)FDA Link 11/2022

Therapy/Procedure

48	Therapeutics 11/2023 - 06/2006
16	Drug Therapy (Chemotherapy) 01/2023 - 06/2006
2	Aftercare (After-Treatment) 06/2018 - 01/2017